Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 779-783

  Su, Young Kim ^a   Dabb, Alix A ^a   Glenn, Donald J ^a   Snyder, Kristen M ^a   Chuk, Meredith K ^a   Loeb, David M ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Pentamidine; Pneumocystis pneumonia; Prophylaxis

Indexed keywords

CARBOPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; PENTAMIDINE; THIOTEPA; TOPOTECAN;

APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE ENTEROPATHY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; BRONCHOSCOPY; CHILD; CHILDHOOD CANCER; CONGENITAL NEUTROPENIA; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTEROPATHY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LEUKEMIA; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOSA INFLAMMATION; NEUTROPENIA; PATIENT COMPLIANCE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYMPTOM;

ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INJECTIONS, INTRAVENOUS; NEOPLASMS; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 40449132930     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21287     Document Type: Article

References (16)

1. Pifer LL, Hughes WT, Stagno S, et al. Pneumocystis carinii infection: Evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978;61:35-41.
2. Hughes WT, Feldman S, Chaudhary SC, et al. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 1978;92:285-291.
3. Hughes WT. Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. J Infect Dis 1984;150:305-306.
4. Vasconcelles MJ, Bernardo MVP, King C, et al. Aerosolized pentamidine as Pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000;6:35-43.
5. Marras TK, Sanders K, Lipton JH, et al. Aerosolized pentamidine prophylaxis for Pneumocytis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis 2002;4:66-74.
6. Weinthal J, Frost JD, Briones G, et al. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia. J Clin Oncol 1994;12:136-140.
7. Mustafa MM, Pappo A, Cash J, et al. Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/sulfamethoxazole. J Clin Oncol 1994;12:258-261.
8. O'Sullivan BP, Spaulding R. The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia. Pediatr Pulmonol 1994;18:228-231.
9. Ena J, Amador C, Pasquau F, et al. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clin Infect Dis 1994;18:901-904.
10. Gupta M, Stephenson K, Gauar S, et al. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection. Pediatr Pulmonol Suppl 1997;16:199-200.
11. Chan C, Montaner J, Lefebvre EA, et al. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J Infect Dis 1999;180:369-376.
12. Colby C, McAfee SL, Sackstein R, et al. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/ sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999;24:897-902.
13. Madden RM, Pui CH, Hughes WT, et al. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Cancer 2007;109:1654-1658.
14. Beard CB, Fox MR, Lawrence GG, et al. Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological implications. J Infect Dis 2005;192:1815-1818.
15. Iliades P, Meshnick SR, Macreadie IG. Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system. Microb Drug Resist 2005;11:1-8.
16. Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005;19:801-805.